Increased ROS levels activate AMPK-ULK1-mediated mitophagy to promote pseudorabies virus replication

Yuan Zhao1, Xiaoyi Qi1, Zhenbang Zhu1

  • 1Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.

Veterinary Research
|July 21, 2025
PubMed

Insights

Pseudorabies virus (PRV) infection causes oxidative stress by disrupting mitochondria and hindering ROS clearance. This allows PRV to evade immune responses, promoting viral replication.

Area of Science:

  • Virology
  • Cellular Biology
  • Immunology

Background:

  • Oxidative stress is implicated in viral pathogenesis.
  • Reactive oxygen species (ROS) play a critical role in cellular processes.

Purpose of the Study:

  • To investigate the role of ROS in pseudorabies virus (PRV) replication.
  • To elucidate the mechanism by which PRV utilizes ROS to evade host immunity.

Main Methods:

  • Investigated PRV-induced changes in mitochondrial function and ROS production.
  • Analyzed the cellular localization and activity of Nrf2.
  • Examined the activation of the AMPK-ULK1 axis and mitophagy.
  • Assessed the impact on MAVS-mediated type I interferon responses.

Main Results:

  • PRV infection increased ER-mitochondria contact, leading to elevated mitochondrial Ca2+ (mtCa2+), loss of mitochondrial membrane potential (MMP), and excessive ROS production.
  • PRV infection sequestered Nrf2 in the cytoplasm, inhibiting ROS scavenging.
  • Elevated ROS activated the AMPK-ULK1 axis, initiating PINK1-Parkin-dependent mitophagy.
  • Mitophagy degraded MAVS, suppressing type I interferon responses and promoting viral replication.

Conclusions:

  • PRV exploits oxidative stress to suppress host antiviral immunity.
  • ROS accumulation facilitates viral replication by inhibiting interferon responses.
  • Findings provide a basis for ROS-targeted antiviral strategies against PRV.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K